Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
V116517 in Postherpetic Neuralgia
NCT01688947Phase 2Completed
- Sponsor
- Purdue Pharma
- Start
- Sep 2012
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of V116517 in postherpetic neuralgia (PHN), sponsored by Purdue Pharma. Started Sep 2012; status: completed.
02
Drugs
V116517
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT01688947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01688947.